Thrombosomes® in Bleeding Thrombocytopenic Patients Study

Clinical trial NCT04631211 · TERMINATED

Trial details

NCT number: NCT04631211
Sponsor: Cellphire Therapeutics, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Thrombocytopenia Hematologic Malignancy Bone Marrow Aplasia Myeloproliferative Disorders Myelodysplastic Syndromes Platelet Refractoriness

Start date: 2021-03-05
Primary completion: 2022-01-07
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.